FDA Should Play Role In Rx Cost Control, Ex-HHS Assistant Sec. Slater Says
FDA's mission should be expanded to include a role in controlling the cost of prescription drugs in the U.S., former HHS Assistant Secretary for Health Eve Slater maintains in a Jan. 20 New England Journal of Medicine editorial
You may also be interested in...
FDA's pharmaceutical bar coding final rule has a shorter implementation timeline than the agency previously proposed
Pharmaceutical outcomes research is the "next frontier" for drug development science, FDA Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman, MD, said at a pharmaceutical outcomes research workshop in Tucson, Ariz. Jan. 23
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011